Hodgkin lymphoma trials in Japan

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1Enrolling by invitation
  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Where

  Nagoya, Tokyo

  Age

  18 years and over

  People

  120 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06788509 · EU 2024-515457-21-00
• Phase 1Taking people
  A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  Where

  Chiba, Okayama, Tokyo

  Age

  18 years and over

  People

  460 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07226843 · EU 2025-523601-16-00
• Phase 2Taking people
  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Where

  Chiba, Kashiwa, Kōtoku, Kumamoto, Niigata, Okayama, Osaka, Yokohama

  Age

  18 years and over

  People

  270 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06526793 · EU 2023-505789-27-00
• Phase 1/2Taking people
  AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  Where

  Bunkyō City, Kōtoku

  Age

  12 years and over

  People

  161 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06137144 · EU 2023-506747-42-00
• No phaseTaking people
  A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

  Where

  Tokyo

  Age

  Up to 18 years

  People

  8

  Run by

  Takeda

  See details and how to joinNCT05481437